Panacea Biotec Fair Value
Panacea Biotec (PANACEABIO) average fair value is ₹1697.85 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹424.3 (+300.15%), fair value range ₹107.55–₹3601.0. For live price and a broader fundamental view, visit Panacea Biotec share price today.
Fair Value Analysis Export
PANACEABIO Fair Value vs Current Price — Valuation Summary
PANACEABIO average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Examine PANACEABIO quarterly results for recent quarterly revenue, profit and EPS trends.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
PANACEABIO Fair Value Analysis — Data Sources & Coverage
Panacea Biotec financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. See Panacea Biotec P/B valuation to compare market price against book value per share.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
PANACEABIO vs Healthcare Sector Peers — P/E, P/B & Market Cap
Panacea Biotec P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.